178 related articles for article (PubMed ID: 35702731)
1. Autologous cellular therapy for cerebral palsy: a randomized, crossover trial.
Cox CS; Juranek J; Kosmach S; Pedroza C; Thakur N; Dempsey A; Rennie K; Scott MC; Jackson M; Kumar A; Aertker B; Caplan H; Triolo F; Savitz SI
Brain Commun; 2022; 4(3):fcac131. PubMed ID: 35702731
[TBL] [Abstract][Full Text] [Related]
2. Effect of Autologous Cord Blood Infusion on Motor Function and Brain Connectivity in Young Children with Cerebral Palsy: A Randomized, Placebo-Controlled Trial.
Sun JM; Song AW; Case LE; Mikati MA; Gustafson KE; Simmons R; Goldstein R; Petry J; McLaughlin C; Waters-Pick B; Chen LW; Wease S; Blackwell B; Worley G; Troy J; Kurtzberg J
Stem Cells Transl Med; 2017 Dec; 6(12):2071-2078. PubMed ID: 29080265
[TBL] [Abstract][Full Text] [Related]
3. Administration of Autologous Bone Marrow-Derived Stem Cells for Treatment of Cerebral Palsy Patients: A Proof of Concept.
Bansal H; Singh L; Verma P; Agrawal A; Leon J; Sundell IB; Koka PS
J Stem Cells; 2016; 11(1):37-49. PubMed ID: 28296863
[TBL] [Abstract][Full Text] [Related]
4. DTI Tract-Based Quantitative Susceptibility Mapping: An Initial Feasibility Study to Investigate the Potential Role of Myelination in Brain Connectivity Change in Cerebral Palsy Patients During Autologous Cord Blood Cell Therapy Using a Rotationally-Invariant Quantitative Measure.
Zhang L; Ellor S; Sun JM; Liu C; Kurtzburg J; Song AW
J Magn Reson Imaging; 2021 Jan; 53(1):251-258. PubMed ID: 32677156
[TBL] [Abstract][Full Text] [Related]
5. The safety and efficacy of umbilical cord blood mononuclear cells in individuals with spastic cerebral palsy: a randomized double-blind sham-controlled clinical trial.
Zarrabi M; Akbari MG; Amanat M; Majmaa A; Moaiedi AR; Montazerlotfelahi H; Nouri M; Hamidieh AA; Badv RS; Karimi H; Rabbani A; Mohebbi A; Rahimi-Dehgolan S; Rahimi R; Dehghan E; Vosough M; Abroun S; Shamsabadi FM; Tavasoli AR; Alizadeh H; Pak N; Zamani GR; Mohammadi M; Javadzadeh M; Ghofrani M; Hassanpour SH; Heidari M; Taghdiri MM; Mohseni MJ; Noparast Z; Masoomi S; Goudarzi M; Mohamadpour M; Shodjaee R; Samimi S; Mohammad M; Gholami M; Vafaei N; Koochakzadeh L; Valizadeh A; Malamiri RA; Ashrafi MR
BMC Neurol; 2022 Mar; 22(1):123. PubMed ID: 35351020
[TBL] [Abstract][Full Text] [Related]
6. Motor function and safety after allogeneic cord blood and cord tissue-derived mesenchymal stromal cells in cerebral palsy: An open-label, randomized trial.
Sun JM; Case LE; McLaughlin C; Burgess A; Skergan N; Crane S; Jasien JM; Mikati MA; Troy J; Kurtzberg J
Dev Med Child Neurol; 2022 Dec; 64(12):1477-1486. PubMed ID: 35811372
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. Maintenance of the synergistic effects of cord blood cells and erythropoietin combination therapy after additional cord blood infusion in children with cerebral palsy: 1-year open-label extension study of randomized placebo-controlled trial.
Suh MR; Min K; Cho KH; Kim J; Lim I; Park M; Noh EM; Kim MY
Stem Cell Res Ther; 2023 Dec; 14(1):362. PubMed ID: 38087394
[TBL] [Abstract][Full Text] [Related]
9. Neural stem cell-like cells derived from autologous bone mesenchymal stem cells for the treatment of patients with cerebral palsy.
Chen G; Wang Y; Xu Z; Fang F; Xu R; Wang Y; Hu X; Fan L; Liu H
J Transl Med; 2013 Jan; 11():21. PubMed ID: 23351389
[TBL] [Abstract][Full Text] [Related]
10. Potentiation of cord blood cell therapy with erythropoietin for children with CP: a 2 × 2 factorial randomized placebo-controlled trial.
Min K; Suh MR; Cho KH; Park W; Kang MS; Jang SJ; Kim SH; Rhie S; Choi JI; Kim HJ; Cha KY; Kim M
Stem Cell Res Ther; 2020 Nov; 11(1):509. PubMed ID: 33246489
[TBL] [Abstract][Full Text] [Related]
11. A Randomized, Placebo-Controlled Trial of Human Umbilical Cord Blood Mesenchymal Stem Cell Infusion for Children With Cerebral Palsy.
Huang L; Zhang C; Gu J; Wu W; Shen Z; Zhou X; Lu H
Cell Transplant; 2018 Feb; 27(2):325-334. PubMed ID: 29637820
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of autologous bone marrow mononuclear cells for cerebral palsy: an open label uncontrolled clinical trial.
Nguyen LT; Nguyen AT; Vu CD; Ngo DV; Bui AV
BMC Pediatr; 2017 Apr; 17(1):104. PubMed ID: 28403842
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Severe Adult Traumatic Brain Injury Using Bone Marrow Mononuclear Cells.
Cox CS; Hetz RA; Liao GP; Aertker BM; Ewing-Cobbs L; Juranek J; Savitz SI; Jackson ML; Romanowska-Pawliczek AM; Triolo F; Dash PK; Pedroza C; Lee DA; Worth L; Aisiku IP; Choi HA; Holcomb JB; Kitagawa RS
Stem Cells; 2017 Apr; 35(4):1065-1079. PubMed ID: 27800660
[TBL] [Abstract][Full Text] [Related]
14. Autologous bone marrow mononuclear cells to treat severe traumatic brain injury in children.
Cox CS; Notrica DM; Juranek J; Miller JH; Triolo F; Kosmach S; Savitz SI; Adelson PD; Pedroza C; Olson SD; Scott MC; Kumar A; Aertker BM; Caplan HW; Jackson ML; Gill BS; Hetz RA; Lavoie MS; Ewing-Cobbs L
Brain; 2024 May; 147(5):1914-1925. PubMed ID: 38181433
[TBL] [Abstract][Full Text] [Related]
15. Clinical and imaging outcomes after intrathecal injection of umbilical cord tissue mesenchymal stem cells in cerebral palsy: a randomized double-blind sham-controlled clinical trial.
Amanat M; Majmaa A; Zarrabi M; Nouri M; Akbari MG; Moaiedi AR; Ghaemi O; Zamani F; Najafi S; Badv RS; Vosough M; Hamidieh AA; Salehi M; Montazerlotfelahi H; Tavasoli AR; Heidari M; Mohebi H; Fatemi A; Garakani A; Ashrafi MR
Stem Cell Res Ther; 2021 Aug; 12(1):439. PubMed ID: 34362453
[TBL] [Abstract][Full Text] [Related]
16. Neuroregenerative potential of intravenous G-CSF and autologous peripheral blood stem cells in children with cerebral palsy: a randomized, double-blind, cross-over study.
Rah WJ; Lee YH; Moon JH; Jun HJ; Kang HR; Koh H; Eom HJ; Lee JY; Lee YJ; Kim JY; Choi YY; Park K; Kim MJ; Kim SH
J Transl Med; 2017 Jan; 15(1):16. PubMed ID: 28109298
[TBL] [Abstract][Full Text] [Related]
17. Effects of bone marrow mesenchymal stromal cells on gross motor function measure scores of children with cerebral palsy: a preliminary clinical study.
Wang X; Cheng H; Hua R; Yang J; Dai G; Zhang Z; Wang R; Qin C; An Y
Cytotherapy; 2013 Dec; 15(12):1549-62. PubMed ID: 24100132
[TBL] [Abstract][Full Text] [Related]
18. Bisphosphonate use in children with cerebral palsy.
Hurley T; Zareen Z; Stewart P; McDonnell C; McDonald D; Molloy E
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD012756. PubMed ID: 34224134
[TBL] [Abstract][Full Text] [Related]
19. Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy]).
Bartolucci J; Verdugo FJ; González PL; Larrea RE; Abarzua E; Goset C; Rojo P; Palma I; Lamich R; Pedreros PA; Valdivia G; Lopez VM; Nazzal C; Alcayaga-Miranda F; Cuenca J; Brobeck MJ; Patel AN; Figueroa FE; Khoury M
Circ Res; 2017 Oct; 121(10):1192-1204. PubMed ID: 28974553
[TBL] [Abstract][Full Text] [Related]
20. Safety and feasibility of autologous cord blood infusion for improving motor function in young children with cerebral palsy in Japan: A single-center study.
Kikuchi H; Saitoh S; Tsuno T; Hosoda R; Baba N; Wang F; Mitsuda N; Tsuda M; Maeda N; Sagara Y; Fujieda M
Brain Dev; 2022 Nov; 44(10):681-689. PubMed ID: 36050140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
